Enlightening the promising role of nanoparticle-based treatments against Naegleria fowleri-induced primary amoebic meningoencephalitis: A brain-eating disease
- 17 December 2024
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 199, 107234
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Recurring seasonal cases of Naegleria fowleri (Brain‐Eating Amoeba) in Pakistan: A rapidly growing threatHealth Science Reports, 2024
- Applications of Gold and Silver Nanoparticles in TheranosticsApplied Biochemistry and Biotechnology, 2022
- A case report of primary amebic meningoencephalitis in North FloridaIDCases, 2021
- Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebaeExperimental Parasitology, 2020
- A case of primary amebic meningoencephalitis caused by Naegleria fowleri in BangladeshParasitology Research, 2019
- Biology and pathogenesis of Naegleria fowleriActa Tropica, 2016
- What do we know by now about the genus Naegleria?Experimental Parasitology, 2014
- Herbal Medicine and Biotechnology for the Benefit of Human Health2014
- Youngest Survivor of Naegleria MeningitisIndian Journal of Pediatrics, 2012
- Nitric oxide production and nitric oxide synthase immunoreactivity in Naegleria fowleriParasitology Research, 2007